Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immucell (ICCC) Non-cash Items (2017 - 2025)

Immucell (ICCC) has disclosed Non-cash Items for 9 consecutive years, with $14200.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Non-cash Items fell 96.72% year-over-year to $14200.0, compared with a TTM value of $14200.0 through Sep 2025, down 96.72%, and an annual FY2024 reading of -$870558.0, up 18.72% over the prior year.
  • Non-cash Items was $14200.0 for Q3 2025 at Immucell, down from $514375.0 in the prior quarter.
  • Across five years, Non-cash Items topped out at $1.3 million in Q1 2022 and bottomed at -$1.1 million in Q2 2023.
  • Average Non-cash Items over 5 years is $92642.9, with a median of $433317.0 recorded in 2024.
  • The sharpest move saw Non-cash Items surged 1785.0% in 2021, then crashed 309.08% in 2025.
  • Year by year, Non-cash Items stood at $468425.0 in 2021, then crashed by 241.18% to -$661310.0 in 2022, then crashed by 61.97% to -$1.1 million in 2023, then increased by 18.72% to -$870558.0 in 2024, then soared by 101.63% to $14200.0 in 2025.
  • Business Quant data shows Non-cash Items for ICCC at $14200.0 in Q3 2025, $514375.0 in Q2 2025, and -$1.1 million in Q1 2025.